-
1
-
-
26644458632
-
Preparation of antiviral nucleosides and methods for treating hepatitis C virus.
-
WO 2001090121, CAN 136:6296, 296pp
-
Sommadossi, J.-P.; LaColla, P. Preparation of antiviral nucleosides and methods for treating hepatitis C virus. 2001, WO 2001090121, CAN 136:6296, 296pp.
-
(2001)
-
-
Sommadossi, J.-P.1
LaColla, P.2
-
2
-
-
36949009053
-
-
Sommadossi, J.-P.; LaColla, P. Methods and compositions using modified nucleosides for treating flaviviruses and pestiviruses. 2001, WO 2001, 092282, CAN 136:590, 302pp.
-
Sommadossi, J.-P.; LaColla, P. Methods and compositions using modified nucleosides for treating flaviviruses and pestiviruses. 2001, WO 2001, 092282, CAN 136:590, 302pp.
-
-
-
-
3
-
-
33745217239
-
Enhanced antiviral efficacy for valopicitabine (NM283) plus PEG-Interferon in hepatitis C patients with HCV genotype-1 infection: Results of a phase Iia multicenter trial
-
a) Afdhal, N.; Rodriguez-Torres, M.; Lawitz, E.; Godofsky, E.; Chao, G.; Fielman, B.; Knox, S.; Brown, N. Enhanced antiviral efficacy for valopicitabine (NM283) plus PEG-Interferon in hepatitis C patients with HCV genotype-1 infection: Results of a phase Iia multicenter trial. J. Hepatol. 2005, 42 (Suppl. 2), 39-40;
-
(2005)
J. Hepatol
, vol.42
, Issue.SUPPL. 2
, pp. 39-40
-
-
Afdhal, N.1
Rodriguez-Torres, M.2
Lawitz, E.3
Godofsky, E.4
Chao, G.5
Fielman, B.6
Knox, S.7
Brown, N.8
-
4
-
-
33746230996
-
Pharmacokinetics and pharmacodynamics of valopicitabine (NM 283), a new nucleoside HCV polymerase inhibitor: Results of a phase I/II dose-escalation trial in patients with HCV-1 infection
-
b) Zhou, X. J.; Afdhal, N.; Godofsky, E.; Dienstag, J.; Rustgi, V.; Schick, L.; McInery, D.; Fielman, B.; Brown, N. Pharmacokinetics and pharmacodynamics of valopicitabine (NM 283), a new nucleoside HCV polymerase inhibitor: Results of a phase I/II dose-escalation trial in patients with HCV-1 infection. J. Hepatol. 2005, 42 (Suppl. 2), 229.
-
(2005)
J. Hepatol
, vol.42
, Issue.SUPPL. 2
, pp. 229
-
-
Zhou, X.J.1
Afdhal, N.2
Godofsky, E.3
Dienstag, J.4
Rustgi, V.5
Schick, L.6
McInery, D.7
Fielman, B.8
Brown, N.9
-
5
-
-
0037284517
-
Synthesis of 1′-C-fluoromethyl-ddC by Selectfluor-induced glycosylation of exo-glycals
-
Molas, P.; Díaz, Y.; Matheu, M.I.; Castillón, S. Synthesis of 1′-C-fluoromethyl-ddC by Selectfluor-induced glycosylation of exo-glycals. Synlett 2003, 2, 207-210.
-
(2003)
Synlett
, vol.2
, pp. 207-210
-
-
Molas, P.1
Díaz, Y.2
Matheu, M.I.3
Castillón, S.4
-
6
-
-
0000269618
-
Dichloromethylenation of lactones. 6. Efficient synthesis of dichloroolefins from lactones and acetates using triphenylphosphine and tetrachloromethan
-
a) Lakhrissi, M.; Chapleur, Y. Dichloromethylenation of lactones. 6. Efficient synthesis of dichloroolefins from lactones and acetates using triphenylphosphine and tetrachloromethan. J. Org.Chem.1994, 59 (19), 5752-5757;
-
(1994)
J. Org.Chem
, vol.59
, Issue.19
, pp. 5752-5757
-
-
Lakhrissi, M.1
Chapleur, Y.2
-
7
-
-
37049109647
-
A convenient synthesis of substituted chiral tetrahydrofurans from sugar. γ-lactones
-
b) Chapleur, Y. A convenient synthesis of substituted chiral tetrahydrofurans from sugar. γ-lactones. J. Chem. Soc., Chem. Commun. 1984, 449-450.
-
(1984)
J. Chem. Soc., Chem. Commun
, pp. 449-450
-
-
Chapleur, Y.1
-
8
-
-
36949031528
-
-
Lakhrissi, M.; Bandzouzi, A.; Chapleur, Y. Carbohydrate Lett. 1995, 1, 307-314.
-
(1995)
Carbohydrate Lett
, vol.1
, pp. 307-314
-
-
Lakhrissi, M.1
Bandzouzi, A.2
Chapleur, Y.3
-
9
-
-
0141456064
-
Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents
-
Buckwold, V.E.; Beer, B.E.; Donis, R.O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res. 2003, 60, 1-15.
-
(2003)
Antiviral Res
, vol.60
, pp. 1-15
-
-
Buckwold, V.E.1
Beer, B.E.2
Donis, R.O.3
|